These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 30689583)

  • 1. Long-Term Trazodone Use and Cognition: A Potential Therapeutic Role for Slow-Wave Sleep Enhancers.
    La AL; Walsh CM; Neylan TC; Vossel KA; Yaffe K; Krystal AD; Miller BL; Karageorgiou E
    J Alzheimers Dis; 2019; 67(3):911-921. PubMed ID: 30689583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Randomized-Controlled Trial Targeting Cognition in Early Alzheimer's Disease by Improving Sleep with Trazodone (REST).
    Eyob E; Shaw JS; Bakker A; Munro C; Spira A; Wu M; Rabinowitz JA; Peters M; Wanigatunga S; Zipunnikov V; Thompson R; Burhanullah MH; Leoutsakos JM; Rosenberg P; Greenberg B
    J Alzheimers Dis; 2024; 101(s1):S205-S215. PubMed ID: 39422935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapies for sleep disturbances in Alzheimer's disease.
    McCleery J; Cohen DA; Sharpley AL
    Cochrane Database Syst Rev; 2014 Mar; (3):CD009178. PubMed ID: 24659320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of trazodone on human cognition: a systematic review.
    Gonçalo AMG; Vieira-Coelho MA
    Eur J Clin Pharmacol; 2021 Nov; 77(11):1623-1637. PubMed ID: 34097124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Alzheimer's Disease: Trazodone, Sleep, Serotonin, Norepinephrine, and Future Directions.
    Ashford JW
    J Alzheimers Dis; 2019; 67(3):923-930. PubMed ID: 30776014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trazodone improves the results of cognitive behaviour therapy of primary insomnia in non-depressed patients.
    Zavesicka L; Brunovsky M; Horacek J; Matousek M; Sos P; Krajca V; Höschl C
    Neuro Endocrinol Lett; 2008 Dec; 29(6):895-901. PubMed ID: 19112384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive, psychomotor and polysomnographic effects of trazodone in primary insomniacs.
    Roth AJ; McCall WV; Liguori A
    J Sleep Res; 2011 Dec; 20(4):552-8. PubMed ID: 21623982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer's disease: a 6-month, randomized, placebo-controlled, multicenter trial.
    Wade AG; Farmer M; Harari G; Fund N; Laudon M; Nir T; Frydman-Marom A; Zisapel N
    Clin Interv Aging; 2014; 9():947-61. PubMed ID: 24971004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insomnia in somatoform pain disorder: sleep laboratory studies on differences to controls and acute effects of trazodone, evaluated by the Somnolyzer 24 x 7 and the Siesta database.
    Saletu B; Prause W; Anderer P; Mandl M; Aigner M; Mikova O; Saletu-Zyhlarz GM
    Neuropsychobiology; 2005; 51(3):148-63. PubMed ID: 15838186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insomnia in depression: differences in objective and subjective sleep and awakening quality to normal controls and acute effects of trazodone.
    Saletu-Zyhlarz GM; Abu-Bakr MH; Anderer P; Gruber G; Mandl M; Strobl R; Gollner D; Prause W; Saletu B
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):249-60. PubMed ID: 11817501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressant Use and Cognitive Outcomes in Very Old Women.
    Leng Y; Diem SJ; Stone KL; Yaffe K
    J Gerontol A Biol Sci Med Sci; 2018 Sep; 73(10):1390-1395. PubMed ID: 29244058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Confirmation of the neurophysiologically predicted therapeutic effects of trazodone on its target symptoms depression, anxiety and insomnia by postmarketing clinical studies with a controlled-release formulation in depressed outpatients.
    Saletu-Zyhlarz GM; Anderer P; Arnold O; Saletu B
    Neuropsychobiology; 2003; 48(4):194-208. PubMed ID: 14673218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-Administered Gerocognitive Examination: longitudinal cohort testing for the early detection of dementia conversion.
    Scharre DW; Chang SI; Nagaraja HN; Wheeler NC; Kataki M
    Alzheimers Res Ther; 2021 Dec; 13(1):192. PubMed ID: 34872596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Psychotropic Medication on Cognition, Caregiver Burden, and Neuropsychiatric Symptoms in Alzheimer's Disease over 12 Months: Results from a Prospective Registry of Dementia in Austria (PRODEM).
    Pirker-Kees A; Dal-Bianco P; Schmidt R
    J Alzheimers Dis; 2019; 71(2):623-630. PubMed ID: 31424389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia.
    Jansen WJ; Ossenkoppele R; Tijms BM; Fagan AM; Hansson O; Klunk WE; van der Flier WM; Villemagne VL; Frisoni GB; Fleisher AS; Lleó A; Mintun MA; Wallin A; Engelborghs S; Na DL; Chételat G; Molinuevo JL; Landau SM; Mattsson N; Kornhuber J; Sabri O; Rowe CC; Parnetti L; Popp J; Fladby T; Jagust WJ; Aalten P; Lee DY; Vandenberghe R; Resende de Oliveira C; Kapaki E; Froelich L; Ivanoiu A; Gabryelewicz T; Verbeek MM; Sanchez-Juan P; Hildebrandt H; Camus V; Zboch M; Brooks DJ; Drzezga A; Rinne JO; Newberg A; de Mendonça A; Sarazin M; Rabinovici GD; Madsen K; Kramberger MG; Nordberg A; Mok V; Mroczko B; Wolk DA; Meyer PT; Tsolaki M; Scheltens P; Verhey FRJ; Visser PJ; ; Aarsland D; Alcolea D; Alexander M; Almdahl IS; Arnold SE; Baldeiras I; Barthel H; van Berckel BNM; Blennow K; van Buchem MA; Cavedo E; Chen K; Chipi E; Cohen AD; Förster S; Fortea J; Frederiksen KS; Freund-Levi Y; Gkatzima O; Gordon MF; Grimmer T; Hampel H; Hausner L; Hellwig S; Herukka SK; Johannsen P; Klimkowicz-Mrowiec A; Köhler S; Koglin N; van Laere K; de Leon M; Lisetti V; Maier W; Marcusson J; Meulenbroek O; Møllergård HM; Morris JC; Nordlund A; Novak GP; Paraskevas GP; Perera G; Peters O; Ramakers IHGB; Rami L; Rodríguez-Rodríguez E; Roe CM; Rot U; Rüther E; Santana I; Schröder J; Seo SW; Soininen H; Spiru L; Stomrud E; Struyfs H; Teunissen CE; Vos SJB; van Waalwijk van Doorn LJC; Waldemar G; Wallin ÅK; Wiltfang J; Zetterberg H
    JAMA Psychiatry; 2018 Jan; 75(1):84-95. PubMed ID: 29188296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does behavioral improvement with haloperidol or trazodone treatment depend on psychosis or mood symptoms in patients with dementia?
    Sultzer DL; Gray KF; Gunay I; Wheatley MV; Mahler ME
    J Am Geriatr Soc; 2001 Oct; 49(10):1294-300. PubMed ID: 11890487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trazodone for the treatment of sleep disorders in dementia: an open-label, observational and review study.
    Camargos EF; Pandolfi MB; Freitas MP; Quintas JL; Lima Jde O; Miranda LC; Pimentel W; Medeiros-Souza P
    Arq Neuropsiquiatr; 2011 Feb; 69(1):44-9. PubMed ID: 21359422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trazodone is only slightly faster than fluoxetine in relieving insomnia in adolescents with depressive disorders.
    Kallepalli BR; Bhatara VS; Fogas BS; Tervo RC; Misra LK
    J Child Adolesc Psychopharmacol; 1997; 7(2):97-107. PubMed ID: 9334895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IVIG treatment of mild cognitive impairment due to Alzheimer's disease: a randomised double-blinded exploratory study of the effect on brain atrophy, cognition and conversion to dementia.
    Kile S; Au W; Parise C; Rose K; Donnel T; Hankins A; Chan M; Ghassemi A
    J Neurol Neurosurg Psychiatry; 2017 Feb; 88(2):106-112. PubMed ID: 26420886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of slow wave sleep in the development of dementia and its potential for preventative interventions.
    Wunderlin M; Züst MA; Fehér KD; Klöppel S; Nissen C
    Psychiatry Res Neuroimaging; 2020 Dec; 306():111178. PubMed ID: 32919869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.